P53 functional mutation type in high-grade serous ovarian cancer and clinical outcomes.

Victoria Mandilaras,Swati Garg,Julia V. Burnier,Katherine Karakasis,Lisa Wang,Helen Mackay,Neesha C. Dhani,Marcus O. Butler,Victor Rodriguez Freixinos,Michelle K. Wilson,Cristina Martin-Lorente,Josee-Lyne Ethier,Philippe L. Bedard,Lillian L. Siu,Blaise Clarke,Patricia Shaw,Tracy L. Stockley,Amit M. Oza,Stephanie Lheureux

P53 functional mutation type in high-grade serous ovarian cancer and clinical outcomes.

2016

Victoria Mandilaras
Swati Garg
Julia V. Burnier
Katherine Karakasis
Lisa Wang
Helen Mackay
Neesha C. Dhani
Marcus O. Butler
Victor Rodriguez Freixinos
Michelle K. Wilson
Cristina Martin-Lorente
Josee-Lyne Ethier
Philippe L. Bedard
Lillian L. Siu
Blaise Clarke
Patricia Shaw
Tracy L. Stockley
Amit M. Oza
Stephanie Lheureux

5550Background: Somatic p53 mutations (TP53m) have been reported in most high grade serous ovarian cancers (HGSOC). We aim to investigate the impact of the type of functional TP53m on prognosis and...

Keywords:

Ovarian cancer
Serous fluid
Pathology
Mutation
Medicine
mutation type
Oncology
serous ovarian cancer
Somatic cell
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations